Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (22347)
All Articles published online
|
Publishing Process of This Article
|
Oct 21, 2015 (publication date) through Jul 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stål P. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. World J Gastroenterol 2015; 21(39): 11077-11087 [PMID: 26494963 DOI: 10.3748/wjg.v21.i39.11077] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i39/11077.htm |
| Number | Citing Articles |
| 1 |
David Hudson, Tamoor Afzaal, Hasan Bualbanat, Raaed AlRamdan, Nisha Howarth, Pavithra Parthasarathy, Alia AlDarwish, Emily Stephenson, Yousef Almahanna, Maytham Hussain, Luis Antonio Diaz, Juan Pablo Arab. Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241276334
|
| 2 |
Ridhi Deo, Suranjan Panigrahi. Explainability Analysis of Black Box SVM models for Hepatic Steatosis Screening. 2022 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT) 2022; : 22 doi: 10.1109/HI-POCT54491.2022.9744067
|
| 3 |
Erika Caro-Gómez, Jelver A. Sierra, Juan S. Escobar, Rafael Álvarez-Quintero, Mauricio Naranjo, Sonia Medina, Eliana P. Velásquez-Mejía, Jorge H. Tabares-Guevara, Julio C. Jaramillo, Yudy M. León-Varela, Katalina Muñoz-Durango, José R. Ramírez-Pineda. Green Coffee Extract Improves Cardiometabolic Parameters and Modulates Gut Microbiota in High-Fat-Diet-Fed ApoE-/- Mice. Nutrients 2019; 11(3): 497 doi: 10.3390/nu11030497
|
| 4 |
Amir Mohamed Abdelhamid, Sameh Saber, Rabab S. Hamad, Mustafa Ahmed Abdel-Reheim, Abousree T. Ellethy, Maha M. Amer, Mohamed R. Abdel-Hamed, Enas A. Mohamed, Syed Suhail Ahmed, Hossam A. Elsisi, Mostafa M. Khodeir, Abdullah S. Alkhamiss, AlSalloom A. A., Mawahib Ahmed Elawad Abu Elgasim, Zainab H. Almansour, Basem H. Elesawy, Elsayed A. Elmorsy. STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1454829
|
| 5 |
I. V. Dvoryakovskiy, S. A. Ivleva, Galina M. Dvoryakovskaya, A. N. Surkov, A. S. Potapov, I. E. Smirnov. Modern technologies of ultrasound diagnostics of cirrhosis in chronic liver diseases in children. Russian Pediatric Journal 2019; 19(4): 202 doi: 10.18821/1560-9561-2016-19-4-202-208
|
| 6 |
Meng Yin. Normal Liver Stiffness Values in Children Are the Same as in Adults. Radiology 2020; 297(3): 670 doi: 10.1148/radiol.2020203515
|
| 7 |
Barbara Bottazzi, Antonio Inforzato, Massimo Messa, Marialuisa Barbagallo, Elena Magrini, Cecilia Garlanda, Alberto Mantovani. The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. Journal of Hepatology 2016; 64(6): 1416 doi: 10.1016/j.jhep.2016.02.029
|
| 8 |
Yoojin Lee, Ji-Young Lee. Dietary Interventions in Liver Disease. 2019; : 91 doi: 10.1016/B978-0-12-814466-4.00008-2
|
| 9 |
Xiaoxin X. Wang, Cen Xie, Andrew E. Libby, Suman Ranjit, Jonathan Levi, Komuraiah Myakala, Kanchan Bhasin, Bryce A. Jones, David J. Orlicky, Shogo Takahashi, Alexander Dvornikov, David E. Kleiner, Stephen M. Hewitt, Luciano Adorini, Jeffrey B. Kopp, Kristopher W. Krausz, Avi Rosenberg, James L. McManaman, Charles E. Robertson, Diana Ir, Daniel N. Frank, Yuhuan Luo, Frank J. Gonzalez, Enrico Gratton, Moshe Levi. The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice. Journal of Biological Chemistry 2022; 298(11): 102530 doi: 10.1016/j.jbc.2022.102530
|
| 10 |
Silvia Salvatore. Eosinophilic esophagitis: when pathologists make the difference. Jornal de Pediatria 2022; 98(1): 1 doi: 10.1016/j.jped.2021.08.001
|
| 11 |
Therese Adrian, Mads Hornum, Filip Krag Knop, Thomas Almdal, Peter Rossing, Lisa í Lída, Niels Søndergaard Heinrich, Vincent Oltman Boer, Anouk Marsman, Esben Thade Petersen, Hartwig Roman Siebner, Bo Feldt-Rasmussen. Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease. Nephron 2023; 147(6): 317 doi: 10.1159/000528080
|
| 12 |
Milena Vesković, Milka Pejović, Nikola Šutulović, Dragan Hrnčić, Aleksandra Rašić-Marković, Olivera Stanojlović, Dušan Mladenović. Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison. International Journal of Molecular Sciences 2024; 25(13): 7405 doi: 10.3390/ijms25137405
|
| 13 |
Chao Huang, Xiaoli Wei, Qihui Luo, Yu Xia, Ting Pan, Junbo He, Asad Jahangir, Lanlan Jia, Wentao Liu, Yuanfeng Zou, Lixia Li, Hongrui Guo, Yi Geng, Zhengli Chen. Loss of TRIM67 Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(13): 7475 doi: 10.3390/ijms23137475
|
| 14 |
Adnan Malik, Sadia Javaid, Muhammad Imran Malik, Shahbaz Qureshi. Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis. Annals of Hepatology 2024; 29(6): 101544 doi: 10.1016/j.aohep.2024.101544
|
| 15 |
Gregorio Recaredo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, José Ignacio Herrero, Alberto Benito-Boillos, Mariana Elorz, Josep A. Tur, J. Alfredo Martínez, M. Angeles Zulet, Itziar Abete. Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study. Nutrients 2019; 11(10): 2359 doi: 10.3390/nu11102359
|
| 16 |
Veronia Basaly, Anisha Bhattacharya, Grace L. Guo. Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver disease. Molecular Pharmacology 2025; 107(2): 100014 doi: 10.1016/j.molpha.2024.100014
|
| 17 |
William S. Reiche, Ryan W. Walters, Bryce F. Schutte, Sandeep Mukherjee, Haitam M. Buaisha. Mild Thrombocytopenia, a Predictor of Outcomes After Laparoscopic Cholecystectomy. Journal of Clinical Gastroenterology 2024; 58(5): 507 doi: 10.1097/MCG.0000000000001926
|
| 18 |
Miquel Serra-Burriel, Isabel Graupera, Pere Torán, Maja Thiele, Dominique Roulot, Vincent Wai-Sun Wong, Indra Neil Guha, Núria Fabrellas, Anita Arslanow, Carmen Expósito, Rosario Hernández, Grace Lai-Hung Wong, David Harman, Sarwa Darwish Murad, Aleksander Krag, Guillem Pera, Paolo Angeli, Peter Galle, Guruprasad P. Aithal, Llorenç Caballeria, Laurent Castera, Pere Ginès, Frank Lammert. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia. Journal of Hepatology 2019; 71(6): 1141 doi: 10.1016/j.jhep.2019.08.019
|
| 19 |
Emily Brown, T. Hydes, A. Hamid, D.J. Cuthbertson. Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. Clinical Therapeutics 2021; 43(9): 1476 doi: 10.1016/j.clinthera.2021.07.013
|
| 20 |
Cristina Oana Mărginean, Lorena Elena Meliț, Maria Oana Săsăran. Elastography—A Bona Fide Non-Invasive Method for Assessing Non-Alcoholic Fatty Liver Disease in Children. Applied Sciences 2021; 11(7): 3240 doi: 10.3390/app11073240
|
| 21 |
Venkateswararao Eeda, Nikhil Yuvaraj Patil, Aditya Dilip Joshi, Vibhudutta Awasthi. Advancements in metabolic‐associated steatotic liver disease research: Diagnostics, small molecule developments, and future directions. Hepatology Research 2024; 54(3): 222 doi: 10.1111/hepr.14008
|
| 22 |
Ben Cox, Roberto Trasolini, Ciaran Galts, Eric M Yoshida, Vladimir Marquez. Comparing the performance of Fibrosis-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score with transient elastography scores of people with non-alcoholic fatty liver disease. Canadian Liver Journal 2021; 4(3): 275 doi: 10.3138/canlivj-2021-0004
|
| 23 |
Jia-jie Lv, Yi-chi Zhang, Xin-yu Li, Hong Guo, Cheng-hao Yang. The burden of non-alcoholic fatty liver disease among working-age people in the Western Pacific Region, 1990–2019: an age–period–cohort analysis of the Global Burden of Disease study. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-19047-y
|
| 24 |
Sanghyeok Lim, Seung Hyun Kim, Yongsoo Kim, Young Seo Cho, Tae Yeob Kim, Woo Kyoung Jeong, Joo Hyun Sohn. Coefficient of Variance as Quality Criterion for Evaluation of Advanced Hepatic Fibrosis Using 2D Shear‐Wave Elastography. Journal of Ultrasound in Medicine 2018; 37(2): 355 doi: 10.1002/jum.14341
|
| 25 |
Tong-Shuo Zhang, Hua-Lei Qin, Tong Wang, Hai-Tao Li, Hai Li, Shi-Hai Xia, Xiao-Hui Xiang. Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research. World Journal of Hepatology 2016; 8(33): 1478-1488 doi: 10.4254/wjh.v8.i33.1478
|
| 26 |
Amila Iriskic Atic, Maja Thiele, Alexander Munk, Louise Torp Dalgaard. Circulating miRNAs associated with nonalcoholic fatty liver disease. American Journal of Physiology-Cell Physiology 2023; 324(2): C588 doi: 10.1152/ajpcell.00253.2022
|
| 27 |
Hakan Fotbolcu, Elçin Zorlu. Nonalcoholic fatty liver disease as a multi-systemic disease. World Journal of Gastroenterology 2016; 22(16): 4079-4090 doi: 10.3748/wjg.v22.i16.4079
|
| 28 |
Victor Leonov, Olga Pavlova, Olga Gulenko, Nikolai Zhelonkin, Lyudmila Varfolomeyeva. Fundamental and Applied Scientific Research in the Development of Agriculture in the Far East (AFE-2022). Lecture Notes in Networks and Systems 2024; 733: 1055 doi: 10.1007/978-3-031-37978-9_101
|
| 29 |
Luciana Costa-Silva, Silvia Marinho Ferolla, Agnaldo Soares Lima, Paula Vieira Teixeira Vidigal, Teresa Cristina de Abreu Ferrari. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease. European Journal of Radiology 2018; 98: 82 doi: 10.1016/j.ejrad.2017.11.003
|
| 30 |
Sathiyamoorthy Selladurai, Arun K. Thittai. Towards quantitative quasi-static ultrasound elastography using a reference layer for liver imaging application: A preliminary assessment. Ultrasonics 2019; 93: 7 doi: 10.1016/j.ultras.2018.10.007
|
| 31 |
Tao Huang, Yuan-Qing-Xiao Li, Ming-Yu Zhou, Rui-Han Hu, Gao-Liang Zou, Jian-Chao Li, Shu Feng, Yong-Mei Liu, Chang-Qin Xin, Xue-Ke Zhao. Focal adhesion kinase-related non-kinase ameliorates liver fibrosis by inhibiting aerobic glycolysis <i>via </i>the FAK/Ras/c-myc/ENO1 pathway. World Journal of Gastroenterology 2022; 28(1): 123-139 doi: 10.3748/wjg.v28.i1.123
|
| 32 |
Lin Guan, Xinhe Zhang, Haoyu Tian, Xing Jin, Hang Fan, Ningning Wang, Jing Sun, Dan Li, Jia Li, Xue Wang, Zilu Zeng, Yiling Li. Prevalence and risk factors of metabolic-associated fatty liver disease during 2014–2018 from three cities of Liaoning Province: an epidemiological survey. BMJ Open 2022; 12(2): e047588 doi: 10.1136/bmjopen-2020-047588
|
| 33 |
Kristina Önnerhag, Hannes Hartman, Peter M Nilsson, Stefan Lindgren. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD). Scandinavian Journal of Gastroenterology 2019; 54(3): 328 doi: 10.1080/00365521.2019.1583366
|
| 34 |
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1167 doi: 10.2147/DMSO.S300051
|
| 35 |
Zheng Yang, Daoqing Gong, Xinxiang He, Fei Huang, Yi Sun, Qinming Hu. Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1113789
|
| 36 |
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?. Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
|
| 37 |
Kelly Casler, Karen Trees, Kelly Bosak. Readiness for the epidemic: The adult nonalcoholic fatty liver disease toolkit for primary care nurse practitioners. Journal of the American Association of Nurse Practitioners 2020; 32(4): 323 doi: 10.1097/JXX.0000000000000223
|
| 38 |
Qing-Feng Sun, Liang-Jie Tang, Ming-Jie Wang, Pei-Wu Zhu, Yang-Yang Li, Hong-Lei Ma, Ou-Yang Huang, Liang Hong, Gang Li, Christopher D. Byrne, Giovanni Targher, Wen-Yue Liu, Yan Lu, Ji-Guang Ding, Ming-Hua Zheng. Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.864570
|
| 39 |
Süleyman Coşgun, Derya Ünal, Aysun Çalışkan Kartal, Osman Bedir. Does Breast Feeding Protect Mothers From Obesity?. Cureus 2024; doi: 10.7759/cureus.70217
|
| 40 |
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. The Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
|
| 41 |
Joselyn Allen, Jingtao Zhang, Michael D. Quickel, Mary Kennett, Andrew D. Patterson, Pamela A. Hankey-Giblin. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model. Journal of Proteome Research 2018; 17(9): 3268 doi: 10.1021/acs.jproteome.8b00379
|
| 42 |
Carlos Jiménez-Cortegana, Alba García-Galey, Malika Tami, Pilar del Pino, Isabel Carmona, Soledad López, Gonzalo Alba, Víctor Sánchez-Margalet. Role of Leptin in Non-Alcoholic Fatty Liver Disease. Biomedicines 2021; 9(7): 762 doi: 10.3390/biomedicines9070762
|
| 43 |
Krishna Kumar Varshney, Jeetendra Kumar Gupta, Rajnish Srivastava. Unveiling the Molecular Mechanism of Diosmetin and its Impact on
Multifaceted Cellular Signaling Pathways. Protein & Peptide Letters 2024; 31(4): 275 doi: 10.2174/0109298665294109240323033601
|
| 44 |
Ritesh Chimoriya, Milan K Piya, David Simmons, Golo Ahlenstiel, Vincent Ho. The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 10(1): 95 doi: 10.3390/jcm10010095
|
| 45 |
Ki Choon Sim, Min Ju Kim, Yongwon Cho, Hyun Jin Kim, Beom Jin Park, Deuk Jae Sung, Yeo Eun Han, Na Yeon Han, Tae Hyung Kim, Yoo Jin Lee. Diagnostic Feasibility of Magnetic Resonance Elastography Radiomics Analysis for the Assessment of Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Journal of Computer Assisted Tomography 2022; 46(4): 505 doi: 10.1097/RCT.0000000000001308
|
| 46 |
Yoojin Lee, Tho X. Pham, Minkyung Bae, Siqi Hu, Edward O’Neill, Ock K. Chun, Myung Joo Han, Sung I. Koo, Young‐Ki Park, Ji‐Young Lee. Blackcurrant (Ribes nigrum) Prevents Obesity‐Induced Nonalcoholic Steatohepatitis in Mice. Obesity 2019; 27(1): 112 doi: 10.1002/oby.22353
|
| 47 |
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Application of transient elastography in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2020; 26(2): 128 doi: 10.3350/cmh.2019.0001n
|
| 48 |
Tanmoy Mondal, Coleman I. Smith, Christopher A. Loffredo, Ruth Quartey, Gemeyel Moses, Charles D. Howell, Brent Korba, Bernard Kwabi-Addo, Gail Nunlee-Bland, Leanna R. Rucker, Jheannelle Johnson, Somiranjan Ghosh. Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †. International Journal of Molecular Sciences 2023; 24(23): 16654 doi: 10.3390/ijms242316654
|
| 49 |
Bei Li, Chuan Zhang, Yu-Tao Zhan. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/2784537
|
| 50 |
Claudio Tana, Marco Tana, Stefano Rossi, Mauro Silingardi, Cosima Schiavone. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. Journal of Ultrasound 2016; 19(3): 183 doi: 10.1007/s40477-016-0203-8
|
| 51 |
Jia-li Ma, Ling-ling He, Yu Jiang, Jun-ru Yang, Ping Li, Yao Zang, Hong-shan Wei. New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease. Annals of Hepatology 2020; 19(3): 287 doi: 10.1016/j.aohep.2019.12.007
|
| 52 |
Yao-Yao Zhou, Xiao-Dong Zhou, Sheng-Jie Wu, Xian-Qing Hu, Biao Tang, Sven van Poucke, Xiao-Yan Pan, Wen-Jun Wu, Xue-Mei Gu, Shen-Wen Fu, Ming-Hua Zheng. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis. European Journal of Gastroenterology & Hepatology 2018; 30(6): 631 doi: 10.1097/MEG.0000000000001075
|
| 53 |
Morten A. Karsdal, Kim Henriksen, Mette Juul Nielsen, Inger Byrjalsen, Diana J. Leeming, Stephen Gardner, Zachary Goodman, Keyur Patel, Aleksander Krag, Claus Christiansen, Detlef Schuppan. Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 311(6): G1009 doi: 10.1152/ajpgi.00283.2016
|
| 54 |
Qian Li, Manish Dhyani, Joseph R Grajo, Claude Sirlin, Anthony E Samir. Current status of imaging in nonalcoholic fatty liver disease. World Journal of Hepatology 2018; 10(8): 530-542 doi: 10.4254/wjh.v10.i8.530
|
| 55 |
Mehonaz Sultana, Md Asrarul Islam, Rhema Khairnar, Sunil Kumar. A guide to pathophysiology, signaling pathways, and preclinical models of liver fibrosis. Molecular and Cellular Endocrinology 2025; 598: 112448 doi: 10.1016/j.mce.2024.112448
|
| 56 |
Fan Zhang, Yan Han, Liming Zheng, Jianhong Liu, Yunfei Wu, Zuowei Bao, Longgen Liu, Wenjian Li. Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity 2023; : 2255 doi: 10.2147/DMSO.S417754
|
| 57 |
Wenyi Deng, Wenjing Fan, Tingting Tang, Hengquan Wan, Simin Zhao, Yao Tan, Kwabena Agyare Oware, Jieqiong Tan, Jiequn Li, Shunlin Qu, Ramoji Kosuru. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4. Oxidative Medicine and Cellular Longevity 2022; 2022(1) doi: 10.1155/2022/3589525
|
| 58 |
Taha Aghajanzadeh, Mahmood Talkhabi, Mohammad Reza Zali, Behzad Hatami, Kaveh Baghaei. Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis. Non-coding RNA Research 2023; 8(4): 471 doi: 10.1016/j.ncrna.2023.06.004
|
| 59 |
Andreas Vadarlis, Sofia Chantavaridou, Georgios Kalopitas, Dimitra Rafailia Bakaloudi, Evangelia Karanika, Eirini Tsekitsidi, Michail Chourdakis. Τhe anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysis. Clinical Nutrition 2022; 41(1): 105 doi: 10.1016/j.clnu.2021.11.016
|
| 60 |
Suranjan Panigrahi, Ridhi Deo, Edward A. Liechty. A New Machine Learning-Based Complementary Approach for Screening of NAFLD (Hepatic Steatosis). 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021; : 2343 doi: 10.1109/EMBC46164.2021.9629507
|
| 61 |
Raj A. Shah, Kris V. Kowdley. Serum ferritin as a biomarker for NAFLD: ready for prime time?. Hepatology International 2019; 13(2): 110 doi: 10.1007/s12072-019-09934-7
|
| 62 |
Farahdina Farahdina, Rendi Aji Prihaningtyas, Bagus Setyoboedi, Agnescia Clarissa Sera, Sjamsul Arief. Seeking Liver Fibrosis in Biliary Atresia using De Ritis Ratio. Biomolecular and Health Science Journal 2024; 7(2): 96 doi: 10.4103/bhsj.bhsj_10_24
|
| 63 |
Katie Shen, Achintya D Singh, Jamak Modaresi Esfeh, Jamile Wakim-Fleming. Therapies for non-alcoholic fatty liver disease: A 2022 update. World Journal of Hepatology 2022; 14(9): 1718-1729 doi: 10.4254/wjh.v14.i9.1718
|
| 64 |
Yala K. Reddy, Hemnishil K. Marella, Yu Jiang, Surosree Ganguli, Peter Snell, Pradeep S.B. Podila, Benedict Maliakkal, Sanjaya K. Satapathy. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies. Journal of Clinical and Experimental Hepatology 2020; 10(3): 245 doi: 10.1016/j.jceh.2019.07.002
|
| 65 |
Abdullah S Shaikh, Jenine Zaibaq-Krill, Heather L Stevenson, Shehzad Merwat, Sheharyar Merwat. Glycogenic Hepatopathy as the Etiology of Abnormal Liver Chemistries in an Uncontrolled Type I Diabetic Patient. Cureus 2021; doi: 10.7759/cureus.19755
|
| 66 |
Elena S. George, Stuart K. Roberts, Amanda J. Nicoll, Anjana Reddy, Tonya Paris, Catherine Itsiopoulos, Audrey C. Tierney. Non‐alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence. Internal Medicine Journal 2018; 48(11): 1369 doi: 10.1111/imj.13973
|
| 67 |
Zhong-Hua Wang, Kenneth I Zheng, Xiao-Dong Wang, Jin Qiao, Yang-Yang Li, Li Zhang, Ming-Hua Zheng, Jian Wu. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver. Hepatobiliary & Pancreatic Diseases International 2021; 20(5): 452 doi: 10.1016/j.hbpd.2021.05.008
|
| 68 |
Magdy El-Gohary, Mike Moore, Paul Roderick, Emily Watkins, Joanne Dash, Tina Reinson, Colin Newell, Miranda Kim, Beth Stuart, Taeko Becque, Nick Sheron, Isabelle Chemin. Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care. PLOS ONE 2018; 13(12): e0208798 doi: 10.1371/journal.pone.0208798
|
| 69 |
Zhi Zhang, Huiqing Wen, Bangjian Peng, Jun Weng, Fanhong Zeng. Downregulated microRNA-129-5p by Long Non-coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-alcoholic Steatohepatitis. Frontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.563265
|
| 70 |
Feruze Yilmaz Enc, Celal Ulasoglu, Alev Bakir, Yusuf Yilmaz. The interaction between current smoking and hemoglobin on the risk of advanced fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2020; 32(5): 597 doi: 10.1097/MEG.0000000000001536
|
| 71 |
Safa Hoodeshenas, Meng Yin, Sudhakar Kundapur Venkatesh. Magnetic Resonance Elastography of Liver. Topics in Magnetic Resonance Imaging 2018; 27(5): 319 doi: 10.1097/RMR.0000000000000177
|
| 72 |
Natalie Rodriguez, Phillipp Hartmann. Antiobesity medications in adult and pediatric obesity and metabolic dysfunction–associated steatotic liver disease. Pharmacological Reviews 2025; 77(4): 100058 doi: 10.1016/j.pharmr.2025.100058
|
| 73 |
Ki Choon Sim, Min Ju Kim, Yongwon Cho, Hyun Jin Kim, Beom Jin Park, Deuk Jae Sung, Na Yeon Han, Yeo Eun Han, Tae Hyung Kim, Yoo Jin Lee. Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease. Journal of Korean Medical Science 2022; 37(49) doi: 10.3346/jkms.2022.37.e339
|
| 74 |
Jan Frohlich, Manlio Vinciguerra. Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?. GeroScience 2020; 42(6): 1475 doi: 10.1007/s11357-020-00279-w
|
| 75 |
Patrick H. Alizai, Isabella Lurje, Andreas Kroh, Sophia Schmitz, Tom Luedde, Julia Andruszkow, Ulf P. Neumann, Florian Ulmer. Noninvasive Evaluation of Liver Function in Morbidly Obese Patients. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/4307462
|
| 76 |
Renchao Dong, Xiaobo Yang, Changyuan Wang, Kexin Liu, Zhihao Liu, Xiaodong Ma, Huijun Sun, Xiaokui Huo, Ting Fu, Qiang Meng. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor. Phytomedicine 2019; 53: 134 doi: 10.1016/j.phymed.2018.09.006
|
| 77 |
Xiao-Li He, Yan-Ming He, Dan Zhang, Hong-Shan Li, Qiang Zhang, Sha-Sha Yuan, Zeng Zhang, Yan-Yan Wang, Cheng-Hao Liu, Chao-Hua Fan, Yun-Hao Li, Min Zheng, Hong-Jie Yang, Ping Zhou, Mingbo Zhang. Efficacy and Mechanism of a Chinese Classic Prescription of Yueju in Treating Nonalcoholic Steatohepatitis and Protecting Hepatocytes from Apoptosis. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/8888040
|
| 78 |
Michael K Zijlstra, Anuhya Gampa, Nora Joseph, Amnon Sonnenberg, Claus J Fimmel. Progressive changes in platelet counts and Fib-4 scores precede the diagnosis of advanced fibrosis in NASH patients. World Journal of Hepatology 2023; 15(2): 225-236 doi: 10.4254/wjh.v15.i2.225
|
| 79 |
Pei-Chia Yen, Yu-Tsung Chou, Chung-Hao Li, Zih-Jie Sun, Chih-Hsing Wu, Yin-Fan Chang, Feng-Hwa Lu, Yi-Ching Yang, Chih-Jen Chang, Jin-Shang Wu. Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It. Journal of Clinical Medicine 2022; 11(5): 1445 doi: 10.3390/jcm11051445
|
| 80 |
Liyun Wang, Kahua Liu, Liang Deng, Guanyu Zhou, Wei Qian, Keshu Xu. Exploration of Perturbed Liver Fibrosis-Related Factors and Collagen Type I in Animal Model of Non-Alcoholic Fatty Liver Disease. Applied Biochemistry and Biotechnology 2024; 196(6): 3260 doi: 10.1007/s12010-023-04694-5
|
| 81 |
Yonah B. Esterson, Gregory M. Grimaldi. Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2018; 22(1): 93 doi: 10.1016/j.cld.2017.08.005
|
| 82 |
Ingrid Leherbauer, Iris Stappen. Selected essential oils and their mechanisms for therapeutic use against public health disorders. An overview. Zeitschrift für Naturforschung C 2020; 75(7-8): 205 doi: 10.1515/znc-2020-0007
|
| 83 |
Xianlong Ye, Yingli Chen, Jianying Qi, Shenglong Zhu, Yuanyuan Wu, Jingjing Xiong, Fei Hu, Zhimou Guo, Xinmiao Liang. Design and pharmaceutical evaluation of bifunctional fusion protein of FGF21 and GLP-1 in the treatment of nonalcoholic steatohepatitis. European Journal of Pharmacology 2023; 952: 175811 doi: 10.1016/j.ejphar.2023.175811
|
| 84 |
Jean-Christophe Simard, Jean-François Thibodeau, Martin Leduc, Mikael Tremblay, Alexandre Laverdure, François Sarra-Bournet, William Gagnon, Jugurtha Ouboudinar, Liette Gervais, Alexandra Felton, Sylvie Letourneau, Lilianne Geerts, Marie-Pier Cloutier, Kathy Hince, Ramon Corpuz, Alexandra Blais, Vanessa Marques Quintela, Jean-Simon Duceppe, Shaun D. Abbott, Amélie Blais, Boulos Zacharie, Pierre Laurin, Steven R. Laplante, Christopher R. J. Kennedy, Richard L. Hébert, François A. Leblond, Brigitte Grouix, Lyne Gagnon. Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-69675-8
|
| 85 |
Tasnim Alkayyali, Lubna Qutranji, Eda Kaya, Alev Bakir, Yusuf Yilmaz. Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease. Acta Diabetologica 2020; 57(5): 613 doi: 10.1007/s00592-019-01467-7
|
| 86 |
Deepa V. Cherla, Noe A. Rodriguez, Roman Vangoitsenhoven, Tavankit Singh, Neal Mehta, Arthur J. McCullough, Stacy A. Brethauer, Philip R. Schauer, Ali Aminian. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease. Surgical Endoscopy 2020; 34(5): 2266 doi: 10.1007/s00464-019-07017-0
|
| 87 |
Ahmed El Ray, Valerie Paradis, Ahmed Montasser, Maged Elghannam, Mohamed Shemis, Iris Nessim, Hoda Abu-Taleb, Tarik Asselah, Ashiq Mohamed, Nicolas Poté, Maha Akl, Patrick Marcellin. Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00209-9
|
| 88 |
Sanjana Murali Krishna, Shreelaxmi V Hegde, Monisha Chellathurai, Nayana Juhy Anitha Mohandas, Swetha Guruswamy, Snehal Pandit, Aysha Afra, Shubra Shetty, Chandu Siripuram. Correlation Between Thyroid-Stimulating Hormone (TSH) and Liver Function Test Values in North Karnataka Patients Admitted to a Tertiary Care Hospital. Cureus 2024; doi: 10.7759/cureus.59004
|
| 89 |
Jennifer Berumen, Jacopo Baglieri, Tatiana Kisseleva, Kristin Mekeel. Liver fibrosis: Pathophysiology and clinical implications. WIREs Mechanisms of Disease 2021; 13(1) doi: 10.1002/wsbm.1499
|
| 90 |
Jeong Woo Kim, Young-Sun Lee, Yang Shin Park, Baek-Hui Kim, Soo Yeon Lee, Jong Eun Yeon, Chang Hee Lee. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59601-3
|
| 91 |
Omar Elshaarawy, Johannes Mueller, Sina Straub, Sebastian Mueller. Nicht-alkoholische Fettlebererkrankung. 2022; : 137 doi: 10.1007/978-3-662-62484-5_13
|
| 92 |
Yu-Jie Zhou, Fang-Zhou Ye, Yang-Yang Li, Xiao-Yan Pan, Ying-Xiao Chen, Xi-Xi Wu, Jiao-Jiao Xiong, Wen-Yue Liu, Shi-Hao Xu, Yong-Ping Chen, Ming-Hua Zheng. Individualized risk prediction of significant fibrosis in non‐alcoholic fatty liver disease using a novel nomogram. United European Gastroenterology Journal 2019; 7(8): 1124 doi: 10.1177/2050640619868352
|
| 93 |
T. Hydes, E. Brown, A. Hamid, A.C. Bateman, D.J. Cuthbertson. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. Clinical Therapeutics 2021; 43(9): 1505 doi: 10.1016/j.clinthera.2021.07.012
|
| 94 |
Ozge Yetginoglu, Dilek Barutcu Atas, Yusuf Yilmaz, Arzu Velioglu, Hakki Arikan, Fatma Alibaz-Oner, Haner Direskeneli, Serhan Tuglular, Ebru Asicioglu. Fibroscan detection of fatty liver and liver fibrosis in patients with systemic lupus erythematosus. Lupus 2022; 31(6): 723 doi: 10.1177/09612033221094708
|
| 95 |
Julie F.N. Potier, Andy E. Durham, Raakesh Modi, William Rosenberg, Sophie A. Dash. Investigation of Serum Markers of Hepatic Fibrosis in Equids. Journal of Equine Veterinary Science 2023; 131: 104937 doi: 10.1016/j.jevs.2023.104937
|
| 96 |
Hasan Ozkan, Funda Tuzun, Serpil Taheri, Peyda Korhan, Pınar Akokay, Osman Yılmaz, Nuray Duman, Erdener Özer, Esra Tufan, Abdullah Kumral, Yusuf Özkul. Epigenetic Programming Through Breast Milk and Its Impact on Milk-Siblings Mating. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.569232
|
| 97 |
Semjon Bugaichuk, Verena Wilkens, Karoline Horvatits, Samuel Huber, Ansgar W. Lohse, Johannes Kluwe, Sven Pischke, Thorben Fründt. Non-alcoholic fatty liver disease, in contrast to alcoholic liver disease, is associated with lower socio-economic status: results from a German referral center. Annals of Hepatology 2025; 30(2): 101926 doi: 10.1016/j.aohep.2025.101926
|
| 98 |
Xiatiguli Shamaitijiang, Wandia Kimita, Juyeon Ko, Loren Skudder-Hill, Yutong Liu, Maxim S. Petrov. Relationship of Liver Blood Tests and T1 Relaxation Time With Intra-pancreatic Fat Deposition. Journal of Clinical and Experimental Hepatology 2024; 14(3): 101343 doi: 10.1016/j.jceh.2023.101343
|
| 99 |
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
|
| 100 |
Jie Zhao, Yong-Fen Qi, Yan-Rong Yu. STAT3: A key regulator in liver fibrosis. Annals of Hepatology 2021; 21: 100224 doi: 10.1016/j.aohep.2020.06.010
|
| 101 |
Lixia Li, Xinting Lan, Xi Peng, Shuai Shi, Yanlin Zhao, Wentao Liu, Qihui Luo, Lanlan Jia, Bin Feng, Zhengli Chen, Yuanfeng Zou, Chao Huang. Polysaccharide from Salviae miltiorrhizae Radix et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease through Modulating Intestinal Microbiota-Related Gut–Liver Axis. International Journal of Molecular Sciences 2022; 23(18): 10620 doi: 10.3390/ijms231810620
|
| 102 |
Kelly Casler, Karen Trees, Kelly Bosak. Providing Care for Fatty Liver Disease Patients. Gastroenterology Nursing 2020; 43(5): E184 doi: 10.1097/SGA.0000000000000487
|
| 103 |
Jian Zhang, Catherine A Powell, Matthew K Kay, Ravi Sonkar, Sunitha Meruvu, Mahua Choudhury. Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-γ Pathway via miR-27b-5p Regulation. International Journal of Molecular Sciences 2021; 22(4): 1822 doi: 10.3390/ijms22041822
|
| 104 |
Adisa Poljo, Stephan Kopf, Alba Sulaj, Stephanie Roessler, Thomas Albrecht, Benjamin Goeppert, Sarah Bojko, Beat P. Müller-Stich, Adrian T. Billeter. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis. Surgery for Obesity and Related Diseases 2023; 19(12): 1421 doi: 10.1016/j.soard.2023.07.005
|
| 105 |
Yu-long Bao, Li Wang, Hai-ting Pan, Tai-ran Zhang, Ya-hong Chen, Shan-jing Xu, Xin-li Mao, Shao-wei Li. Animal and Organoid Models of Liver Fibrosis. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.666138
|
| 106 |
Yu‐Ming Cheng, Chia‐Chi Wang. Comparison of Mac‐2 binding protein glycosylation isomer (M2BPGi) with AST to platelet ratio index (APRI), fibrosis 4 Score (FIB‐4), and nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS) for NAFLD patients. Advances in Digestive Medicine 2023; 10(2): 87 doi: 10.1002/aid2.13315
|
| 107 |
Tianhao Zhou, Vik Meadows, Debjyoti Kundu, Konstantina Kyritsi, Travis Owen, Ludovica Ceci, Guido Carpino, Paolo Onori, Eugenio Gaudio, Nan Wu, Shannon Glaser, Burcin Ekser, Gianfranco Alpini, Lindsey Kennedy, Heather Francis. Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling. Hepatology Communications 2022; 6(10): 2715 doi: 10.1002/hep4.2026
|
| 108 |
Sohair M. Abd El-Naby, Naglaa F. Khedr, Nahla E. El-Ashmawy, Amera O. Ibrahim. Proanthocyanidin and mitoglitazone suppress lipogenesis by targeting ferroptosis in metabolic dysfunction-associated steatohepatitis. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04271-z
|
| 109 |
Abbas Ali Tasneem, Nasir Hassan Luck, Zain Majid. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Tropical Doctor 2018; 48(2): 107 doi: 10.1177/0049475517742261
|
| 110 |
Niklas Heucke, Tilo Wuensch, Julia Mohr, Magnus Kaffarnik, Ruza Arsenic, Bruno Sinn, Tobias Müller, Johann Pratschke, Martin Stockmann, Ingolf Sack, Heiko Tzschätzsch. Non‐invasive structure–function assessment of the liver by 2D time‐harmonic elastography and the dynamic Liver MAximum capacity (LiMAx) test. Journal of Gastroenterology and Hepatology 2019; 34(9): 1611 doi: 10.1111/jgh.14629
|
| 111 |
Tamara Milovanovic, Sanja Dragasevic, Milica Stojkovic Lalosevic, Sanja Zgradic, Biljana Milicic, Igor Dumic, Stefan Kmezic, Dusan Saponjski, Andrija Antic, Velimir Markovic, Dragan Popovic. Ultrasonographic Evaluation of Fatty Pancreas in Serbian Patients with Non Alcoholic Fatty Liver Disease—A Cross Sectional Study. Medicina 2019; 55(10): 697 doi: 10.3390/medicina55100697
|
| 112 |
Laura Di Renzo, Giulia Cinelli, Maria Dri, Paola Gualtieri, Alda Attinà, Claudia Leggeri, Giuseppe Cenname, Ernesto Esposito, Alberto Pujia, Gaetano Chiricolo, Chiara Salimei, Antonino De Lorenzo. Mediterranean Personalized Diet Combined with Physical Activity Therapy for the Prevention of Cardiovascular Diseases in Italian Women. Nutrients 2020; 12(11): 3456 doi: 10.3390/nu12113456
|
| 113 |
Masahiro Tamura, Hiroshi Ohta, Tatsuyuki Osuga, Noboru Sasaki, Keitaro Morishita, Mitsuyoshi Takiguchi. Extrahepatic biliary obstruction can interfere with hepatic fibrosis prediction using two‐dimensional shear wave elastography in dogs. Veterinary Radiology & Ultrasound 2021; 62(4): 483 doi: 10.1111/vru.12969
|
| 114 |
Abdo Mahli, Andreas Koch, Kim Fresse, Tobias Schiergens, Wolfgang Erwin Thasler, Christina Schönberger, Ina Bergheim, Anja Bosserhoff, Claus Hellerbrand. Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis. Laboratory Investigation 2018; 98(12): 1614 doi: 10.1038/s41374-018-0112-x
|
| 115 |
Adnan Khan, Heather M. Ross, Natalia Salinas Parra, Sarah L. Chen, Kashyap Chauhan, Makala Wang, Brian Yan, John Magagna, Jake Beiriger, Yash Shah, Taha Shahzad, Dina Halegoua-DeMarzio. Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD). Livers 2022; 2(4): 264 doi: 10.3390/livers2040022
|
| 116 |
Andreas Schmid, Miriam Arians, Thomas Karrasch, Jörn Pons-Kühnemann, Andreas Schäffler, Martin Roderfeld, Elke Roeb. Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy. Journal of Clinical Medicine 2022; 11(7): 1756 doi: 10.3390/jcm11071756
|
| 117 |
Turan Aghayev, Aleksandra M. Mazitova, Jennifer R. Fang, Iuliia O. Peshkova, Matthew Rausch, Manhsin Hung, Kerry F. White, Ricard Masia, Elizaveta K. Titerina, Aliia R. Fatkhullina, Isabelle Cousineau, Simon Turcotte, Dmitry Zhigarev, Anastasiia Marchenko, Svetlana Khoziainova, Petr Makhov, Yin Fei Tan, Andrew V. Kossenkov, David L. Wiest, John Stagg, Xin Wei Wang, Kerry S. Campbell, Amiran K. Dzutsev, Giorgio Trinchieri, Jonathan A. Hill, Sergei I. Grivennikov, Ekaterina K. Koltsova. IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma. Cancer Discovery 2022; 12(8): 1960 doi: 10.1158/2159-8290.CD-20-1628
|
| 118 |
Hyeon Ju Kim, Yoseob Lee, Sungsoon Fang, Won Kim, Hyo Jung Kim, Jae-woo Kim. GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress. BMB Reports 2020; 53(6): 317 doi: 10.5483/BMBRep.2020.53.6.280
|
| 119 |
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
|
| 120 |
Shaza Asif, Nadya M. Morrow, Erin E. Mulvihill, Kyoung-Han Kim. Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.590369
|
| 121 |
Rebecca Bresnahan, Rui Duarte, James Mahon, Sophie Beale, Marty Chaplin, Devarshi Bhattacharyya, Rachel Houten, Katherine Edwards, Sarah Nevitt, Michelle Maden, Angela Boland. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
. Health Technology Assessment 2023; : 1 doi: 10.3310/KGJU3398
|
| 122 |
S. A. Pavlovskyi, N. G. Virstyuk.
DETERMINATION OF FIBER DEVELOPMENT OF LIVER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ASSOCIATED WITH NON-ALCOHOL FATTY LIVER DISEASE
. World of Medicine and Biology 2018; 14(63): 061 doi: 10.26724/2079-8334-2018-1-63-61-64
|
| 123 |
Isabelle Arruda Barbosa, Eloá Mangabeira Santos, Alanna Fernandes Paraíso, Pablo Vinicyus Ferreira Chagas, Luís Paulo Oliveira, João Marcus Oliveira Andrade, Lucyana Conceição Farias, Bruna Mara Aparecida de Carvalho, Alfredo Maurício Batista de Paula, André Luiz Sena Guimarães, Sérgio Henrique Sousa Santos. Liraglutide alters hepatic metabolism in high-fat fed obese mice: A bioinformatic prediction and functional analysis. Meta Gene 2019; 20: 100553 doi: 10.1016/j.mgene.2019.100553
|
| 124 |
Jingxuan Quek, Kai En Chan, Zhen Yu Wong, Caitlyn Tan, Bryan Tan, Wen Hui Lim, Darren Jun Hao Tan, Ansel Shao Pin Tang, Phoebe Tay, Jieling Xiao, Jie Ning Yong, Rebecca Wenling Zeng, Nicholas W S Chew, Benjamin Nah, Anand Kulkarni, Mohammad Shadab Siddiqui, Yock Young Dan, Vincent Wai-Sun Wong, Arun J Sanyal, Mazen Noureddin, Mark Muthiah, Cheng Han Ng. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2023; 8(1): 20 doi: 10.1016/S2468-1253(22)00317-X
|